BioNeutra Global Corporation announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was CAD 5.844 million compared to CAD 10.372 million a year ago. Net loss was CAD 68,629 compared to CAD 913,432 a year ago. Basic eps - continuing operations was CAD 0 compared to basic loss per share from continuing operations of CAD 0.02 a year ago. For the nine months, sales was CAD 19.394 million compared to CAD 28.025 million a year ago. Net loss was CAD 1.024 million compared to CAD 6.704 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.14 a year ago.